Curated Wealth Partners 出售了辉瑞的股票，尽管该公司的收益超过了分析师的预期。 Curated Wealth Partners sold Pfizer shares, despite the company's earnings beating analyst estimates.

投资公司 " 溢价财富伙伴 " 有限公司出售了微小一部分的辉瑞股票,将其持有量减少了1.9%,而诸如Yousif资本管理公司等其他公司则增加了其股份。 Investment firm Curated Wealth Partners LLC sold a small portion of their Pfizer shares, reducing their holdings by 1.9%, while other firms like Yousif Capital Management increased theirs. Pfizer最近报告说,Q1收入为每股0.92美元,超过分析师估计的0.67美元。 Pfizer recently reported Q1 earnings of $0.92 per share, exceeding analyst estimates of $0.67. 尽管如此,与去年同一季度相比,该公司的收入下降了7.8%。 Despite this, the company's revenue was down 7.8% compared to the same quarter last year. 金融机构对辉瑞公司保持“中性”评级,其价格目标各不相同。 Financial institutions have maintained a "neutral" rating on Pfizer, with varied price targets. 该公司在包括心血管病、偏头痛和妇女健康在内的各种治疗领域开发药品和疫苗。 The company develops medicines and vaccines in various therapeutic areas, including cardiovascular, migraine, and women's health.